The World Cardiovascular Drug Market: Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents

Questions: Discounts, Updates etc.

Pages: 265

Price (Single): $3,995.00

Price (Company): $7,990.00

Publication Date: Dec 1, 2007

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

The report will steer marketers through the sheer size and diversity of the current market and the potential of new products that will make this therapeutic category among the most competitive of prescription drug segments.

The following market segments are covered:

Specific diseases and disorders discussed include:

The report details the various categories of cardiovascular drugs and describes U.S. and non-U.S. markets in each of the specific cardiovascular drug areas. Revenues are considered in each subsegment according to type of drug. In addition, top products in each category are reviewed. The report also covers market drivers and trends that are influencing the market, including:

The report further identifies major market factors, which are discussed in detail, and a total market summary is presented.All market data are presented at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year for data was 2004. Historical data are provided for 2002 and 2003, and forecast data are provided for each of the years 2005 through 2009. Historical, base year, and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2004 base year.As part of Kalorama\'s trusted information-gathering process, information and analysis presented in this report are based on extensive interviews with senior management of top companies and other participants in the cardiovascular market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals.

Key information from published literature was used to conduct interviews with over 41 industry executives and product managers to validate and obtain expert opinion on current and future trends in the cardiovascular market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.

Table of Contents

 

TABLE OF EXHIBITS

  • Table 9-2: Marketed Anticoagulant Drugs
  • Table 9-3: Marketed Antiplatelet Drugs
  • Table 9-4: Marketed Thrombolytic Drugs
  • Table 9-5: Total World Prescription Blood Modifier Drug Market 2004-2011
  • Figure 9-1: Total World Prescription Blood Modifier Drug Market 2004-2011
  • Table 9-6: The Global Market for Prescription Blood Modifier Drugs by Type 2004-2011
  • Figure 9-2: Global Market for Prescription Blood Modifier Drugs by Type 2006
  • Table 9-7: Blood Modifier Drugs in Development
  • Table 9-8: Total Global Market for Prescription Blood Modifiers, Revenues and Market Share by Supplier 2006
  • Figure 9-4: Total Global Market for Prescription Blood Modifier Drugs, Market Share by Leading Supplier 2006
      CHAPTER TEN: PRESCRIPTION DIURETIC DRUGS
    • Table 10-1: Marketed Diurectic Drugs
    • Table 10-2: Total World Prescription Diuretic Drugs Market 2004-2011
    • Figure 10-1: Total World Prescription Diuretic Drugs Market 2004-2011
    • Table 10-3: Diuretic Drugs in Development
    • Table 10-4: Total Global Market for Prescription Diuretic Drugs, Revenues and Market Share by Supplier 2006
    • Figure 10-2: Total Global Market for Prescription Diuretic Drugs, Market Share by Leading Supplier 2006
      CHAPTER ELEVEN: PRESCRIPTION OTHER CARDIOVASCULAR DRUGS
    • Table 11-1: Marketed Other Cardiovascular Drugs
    • Table 11-2: Total World Other Cardiovascular Drug Market 2004-2011
    • Figure 11-1: Total World Other Cardiovascular Drug Market 2004-2011
    • Table 11-3: Other Cardiovascular Drugs in Development
    • Table 11-4: Total World Market for Other Cardiovascular Drugs Revenues and Market Share by Supplier 2006
    • Figure 11-5: Total World Market for Other Cardiovascular Drugs Market Share by Leading Supplier 2006
      CHAPTER TWELVE: WORLD MARKET SUMMARY
    • Table 12-1: Total World Prescription Cardiovascular Drug Market 2004-2011
    • Table 12-2 Total World Prescription Cardiovascular Drug Market by Product Segment 2004-2011
    • Figure 12-1: Total World Prescription Cardiovascular Drug Market by Product Segment 2004-2011
    • Figure 12-2: The World Market for Prescription Cardiovascular Drugs by Product Segment Market Share 2006
    • Table 12-3: World Market for Prescription Cardiovascular Drugs Revenues and Segments of Participation by Major Areas of Participation 2006
    • Figure 12-3: World Market for Prescription Cardiovascular Drugs Revenues and Segments of Participation by Major Areas of Participation 2006

    • Other users found this report page using the following search terms: cardiovascular market drugs global cardiovascular ace share 2007 inhibitors prescription world

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.